Private Equity Bigwigs Buy Biomet

Dec 20 2006 | 12:42pm ET

A consortium of private equity heavyweights has agreed to pay $10.9 billion for medical device manufacturer Biomet.

The group includes the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts and Texas Pacific Group.

Warsaw, Ind.-based Biomet designs and manufactures musculoskeletal medical products. The deal, which offers $44 per share and was unanimously approved by Biomet’s board, awaits shareholder approval.


In Depth

PAAMCO: Will Inflation Deflate the Asset Bubble?

Jan 30 2018 | 9:49pm ET

As the U.S. shifts from monetary stimulus to fiscal stimulus, market pricing should...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Boost Hedge Fund Marketing ROI By Raising Your ROO

Feb 14 2018 | 9:57pm ET

Tasked with delivering returns on client capital, a common dilemma for many alternative...